KBC Group NV Has $11.15 Million Stake in Colgate-Palmolive Company (NYSE:CL)
KBC Group NV boosted its stake in Colgate-Palmolive Company (NYSE:CL) by 33.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 152,333 shares of the company’s stock after buying an additional 38,471 shares during the period. KBC Group NV’s holdings in Colgate-Palmolive were worth $11,150,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of CL. Blue Chip Partners Inc. raised its stake in Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock valued at $132,000 after buying an additional 8 shares during the period. Alpha Windward LLC raised its stake in Colgate-Palmolive by 0.6% in the first quarter. Alpha Windward LLC now owns 2,829 shares of the company’s stock valued at $207,000 after buying an additional 18 shares during the period. Northstar Group Inc. raised its stake in Colgate-Palmolive by 0.4% in the first quarter. Northstar Group Inc. now owns 4,850 shares of the company’s stock valued at $356,000 after buying an additional 20 shares during the period. Savant Capital LLC raised its stake in Colgate-Palmolive by 0.3% in the first quarter. Savant Capital LLC now owns 10,526 shares of the company’s stock valued at $770,000 after buying an additional 30 shares during the period. Finally, Evanson Asset Management LLC raised its stake in Colgate-Palmolive by 0.3% in the first quarter. Evanson Asset Management LLC now owns 11,869 shares of the company’s stock valued at $869,000 after buying an additional 32 shares during the period. 73.85% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Company (CL) opened at 71.48 on Monday. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27. The company has a 50 day moving average of $73.87 and a 200 day moving average of $72.62. The firm has a market capitalization of $62.96 billion, a P/E ratio of 26.56 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.72. The company had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business’s revenue for the quarter was down .5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.70 EPS. On average, equities research analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Investors of record on Tuesday, July 18th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.24%. The ex-dividend date is Friday, July 14th. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.
ILLEGAL ACTIVITY WARNING: “KBC Group NV Has $11.15 Million Stake in Colgate-Palmolive Company (NYSE:CL)” was first posted by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/08/07/kbc-group-nv-has-11-15-million-stake-in-colgate-palmolive-company-nysecl.html.
Several analysts have issued reports on the stock. UBS AG reaffirmed a “neutral” rating and set a $78.00 price target (down from $79.00) on shares of Colgate-Palmolive in a research report on Tuesday, May 2nd. Royal Bank Of Canada reaffirmed a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a research report on Monday, April 24th. Jefferies Group LLC assumed coverage on shares of Colgate-Palmolive in a research report on Tuesday, April 18th. They set a “hold” rating and a $78.00 price target on the stock. BidaskClub downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Finally, Wells Fargo & Company reiterated a “market perform” rating on shares of Colgate-Palmolive in a report on Monday, July 24th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $75.82.
In related news, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $75.67, for a total value of $290,043.11. Following the sale, the insider now directly owns 53,022 shares in the company, valued at approximately $4,012,174.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ellen M. Hancock sold 5,057 shares of the business’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $71.91, for a total value of $363,648.87. Following the completion of the sale, the director now owns 199,777 shares in the company, valued at $14,365,964.07. The disclosure for this sale can be found here. Insiders sold a total of 109,097 shares of company stock worth $7,905,278 over the last 90 days. 1.02% of the stock is currently owned by company insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.